The risk of developing ovarian cancer with a BRCA1 mutation is 39–63%, while it is 16.5–27% for BRCA2; the risk for developing male breast cancer due to BRCA1 mutation is 1.2%, while it is 8.9% for BRCA2; the risk of developing prostate cancer in men up to 65 years of age due to BRCA1 mutation is 8.6%, while it is 15% for BRCA2; the risk of developing pancreatic cancer due to BRCA1 mutation is 1–3%, while it is 2–7% for BRCA2 mutation [32]. This evidence concerns the gene BRCA1 and prostate carcinoma.